Lyme Disease Cases Are Increasing. Be prepared with ZEUS Borrelia MTTT™
Lyme disease cases are increasing this year.
Are you prepared?
The CDC recently increased their estimate of the number of Lyme disease cases from 300K to 476K per year. Lyme disease is curable. The faster it is diagnosed and treated, the better the outcome for the patient. Missing a Lyme disease diagnosis can lead to long-term health repercussions for patients. Now is the perfect time to make the benefit-driven promise of a Borrelia MTTT algorithm a reality in your laboratory.
If you want to keep pace with the increasing Lyme disease testing demand expected this year and save valuable time interpreting immunoblots, try the ZEUS Borrelia Modified Two-Tiered Testing (MTTT) algorithm.
The ZEUS Borrelia MTTT™ algorithm improves detection of early Lyme disease by up to 30% compared to the Standard Two-Tiered Testing (STTT) algorithm. The STTT algorithm requires a 2nd-tier immunoblot which adds subjectivity in results interpretation and reduces sensitivity in measuring acute Lyme disease. See what you have been missing by using ZEUS’s MTTT algorithm and replace outdated immunoblots with a 2nd-tier ELISA. Eliminate subjectivity, improve accuracy and boost overall efficiency in your laboratory.
The ZEUS Borrelia MTTT™ reduces turnaround time, allowing patients to access much-needed treatment earlier. Without early treatment, Lyme disease can have a devastating impact on patients.
Learn how easy it is to make the switch to the ZEUS Borrelia MTTT™ algorithm. Schedule your 1:1 consultation with one of our technical specialists, and start getting more accurate and streamlined testing results.
Trust the experts in Lyme disease testing.
Test with Confidence. Test with ZEUS.
See what you've been missing. Contact ZEUS today!
Visit zeuslyme.com to learn more.
The ZEUS Scientific Team